ExploreWatchlistsPricing
  1. US-listed companies
  2. FATE THERAPEUTICS INC
  3. Financials
  4. Common stock and paid-in capital

FATE THERAPEUTICS INC (FATE)

Market cap
$135.27M
P/E ratio
SummaryFinancials
Period EndCommon stock and paid-in capital (Million USD)YoY (%)
Dec 31, 20241,716+8.63%
Dec 31, 20231,580+2.83%
Dec 31, 20221,537+6.07%
Dec 31, 20211,449+53.90%
Dec 31, 2020941+49.82%
Dec 31, 2019628+40.91%
Dec 31, 2018446+50.64%
Dec 31, 2017296+18.87%
Dec 31, 2016249+858513.79%
Dec 31, 20150-99.98%
Dec 31, 2014141+2.46%
Dec 31, 2013137

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat